We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
Products / CNS APIs
CNS APIs

CNS APIs

Inke develops and manufactures API ingredients for use in CNS therapies, as a subsidiary of Neuraxpharm,
a European leader in pharmaceutical products for the central nervous system (CNS)
API Indication Micronised / PSD CEP EU DMF US DMF JP DMF KR DMF CN DMF
Asenapine p Schizophrenia and acute mania
Brexpiprazole Schizophrenia and major depressive disorders
Brivaracetam Antiepileptic
Clomethiazole Insomnia
Eletriptan HBr p Migraine
Olanzapine p Schizophrenia, psychosis
Olanzapine pamoate (sterile) Schizophrenia, psychosis
Quetiapine hemifumarate p Schizophrenia, psychosis
Risperidone p Schizophrenia, psychosis
Rizatriptan benzoate p Migraine
Tetrabenazine Parkinson disease
Tetrabenazine (+) Parkinson disease
Zolmitriptan p Migraine
INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain marketing authorisation. In particular, these products are developed for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC, i.e activities carried out to obtain marketing authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.


© Neuraxpharm / INKE. All rights reserved.